I started as a Clinical Assistant in the department of oncology at the Tom Baker Cancer Centre after which I completed my Internal Medicine and Medical Oncology training at the University of Calgary. I completed a breast cancer and clinical trials fellowship under the supervision of Dr. Jan-Willem Henning at the Tom Baker Cancer Centre in 2024 while working as a part time locum medical oncologist. I am currently a breast medical oncologist at the Arthur J.E Child Comprehensive Cancer Centre in Calgary and Clinical Assistant Professor at the University of Calgary. I am actively involved in breast clinical trials as PI and Sub-PI and have completed the CCTG New investigator practicum in April 2026. My other interests include global oncology initiatives. I am passionate about enhancing patient education and experience in cancer care. I severe as a member of the CCA Quality and Safety Committee. I am also currently involved with a project which is using AI to develop patient education videos for breast cancer patients in Alberta.


Hussain, Marya
Medical Oncology
Clinical Assistant Professor
Web Presence:
Biography
Area of Focus
- Breast Cancer
- Clinical Trials
- Global Oncology
Summary of Research
- Hussain M, Brezden-Masley C, Chia S, Curigliano G, Webster M, Henning J-W. Clinician’s guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer. Therapeutic Advances in Medical Oncology. 2025;17.
- Hussain M, Wong C, Taguedong E, Verma S, Mahsin M, Karim S, Lee-Ying R, Ezeife DA. Impact of Oncology Drug Review Times on Public Funding Recommendations. Current Oncology. 2023; 30(8):7706-7712.
- Hussain M, Abbott M, Zargham R, Pabani A, Khan OF. Evolution of an invasive ductal carcinoma to a small cell carcinoma of the breast: A case report. Medicine (Baltimore). 2022 Jan 14;101(2):e28433.
Area Of Focus
- Breast Cancer
- Clinical Trials
- Global Oncology
Summary Of Research
- Hussain M, Brezden-Masley C, Chia S, Curigliano G, Webster M, Henning J-W. Clinician’s guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer. Therapeutic Advances in Medical Oncology. 2025;17.
- Hussain M, Wong C, Taguedong E, Verma S, Mahsin M, Karim S, Lee-Ying R, Ezeife DA. Impact of Oncology Drug Review Times on Public Funding Recommendations. Current Oncology. 2023; 30(8):7706-7712.
- Hussain M, Abbott M, Zargham R, Pabani A, Khan OF. Evolution of an invasive ductal carcinoma to a small cell carcinoma of the breast: A case report. Medicine (Baltimore). 2022 Jan 14;101(2):e28433.

